Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Business
Mark Sweney and Julia Kollewe

GSK spin-off Haleon begins trading in biggest European listing in a decade

GSK spin-off Haleon begins trading on the London Stock Exchange
GSK spin-off Haleon begins trading on the London Stock Exchange. Photograph: Layton Thompson/Haleon

GSK’s consumer spin-off Haleon, home to brands from Sensodyne toothpaste to Panadol painkillers, has begun trading on the London Stock Exchange in the biggest European listing in a decade.

Haleon shares started trading on Monday morning at 330p, with a market value of about £31bn, but at the end of day one it was £28.5bn.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.